Recruiting Studies
Advanced SearchData: ClinicalTrials.gov · Source of record for eligibility and locations
Top Cities for Small Cell Lung Cancer Clinical Trials
Small Cell Lung Cancer clinical trials are recruiting across 270 cities. Here are the cities with the most active studies:
Small Cell Lung Cancer Trial Phases
51 research organizations are sponsoring small cell lung cancer trials.
About Small Cell Lung Cancer
Small cell lung cancer (SCLC) is an aggressive form of lung cancer that tends to grow and spread faster than non-small cell lung cancer. It is strongly associated with smoking. Treatment typically involves chemotherapy combined with immunotherapy and radiation.
Clinical trials are advancing new treatments for small cell lung cancer. Currently, 100 studies are recruiting a combined 224,861 participants across the United States. Research is being conducted by 51 organizations including University of Utah, SWOG Cancer Research Network, Vanderbilt-Ingram Cancer Center and 48 others.
2026 Small Cell Lung Cancer Research Landscape
As of July 2026, the small cell lung cancer clinical trial landscape includes 100 actively recruiting studies across 270 cities in the United States. These studies are collectively seeking 224,861 participants, with an average enrollment target of 2,249 per study.
The research spans multiple phases of development: 57 studies are in PHASE3, 27 studies are in PHASE2, 20 studies are in PHASE1, 2 studies are in NA. The presence of Phase 3 trials indicates that some small cell lung cancer treatments are in late-stage testing and may be approaching regulatory review.
Research is being led by 51 different organizations, including University of Utah, SWOG Cancer Research Network, Vanderbilt-Ingram Cancer Center, Ohio State University Comprehensive Cancer Center, Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, and 46 others. The large number of sponsors reflects significant research interest and investment in small cell lung cancer treatment advancement.
Geographically, small cell lung cancer trials are most concentrated in Los Angeles, California (25 trials); Duarte, California (17 trials); Boston, Massachusetts (17 trials); New Haven, Connecticut (14 trials); Washington D.C., District of Columbia (14 trials) and 7 other cities.
Featured Small Cell Lung Cancer Studies
Highlighted recruiting studies for small cell lung cancer, selected by enrollment size and research scope.
Machine Learning Approaches to Personalized Therapy for Advanced Non-small Cell Lung Cancer With Real-World Data
This research will leverage machine learning (ML) and causal inference techniques applied to real-world data (RWD) to generate evidence that personalizes treatment strategies for patients with advanced non-small cell lung cancer (aNSCLC). Rather than influencing regulatory decisions or clinical guidelines, the goal of this trial is to refine treatment selection among existing therapeutic options, ...
Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer
This screening and multi-sub-study randomized phase II/III trial will establish a method for genomic screening of similar large cancer populations followed by assigning and accruing simultaneously to a multi-sub-study hybrid Master Protocol (Lung-MAP). The type of cancer trait (biomarker) will determine to which sub-study, within this protocol, a participant will be assigned to compare new targete...
Collecting and Analyzing Tissue Samples From Patients Undergoing Surgery for Non-Small Cell Lung Cancer
RATIONALE: Studying samples of tumor tissue from patients with cancer in the laboratory may help doctors learn more about changes that may occur in RNA and identify biomarkers related to cancer. PURPOSE: This research study is collecting and analyzing lung tissue samples from patients undergoing surgery for non-small cell lung cancer.
Frequently Asked Questions About Small Cell Lung Cancer Clinical Trials
Are there small cell lung cancer clinical trials near me?
Yes, there are 100 small cell lung cancer clinical trials currently recruiting across 270+ cities in the United States, including Los Angeles, California; Duarte, California; Boston, Massachusetts. Browse the studies above to find one at a location convenient for you.
How do I join a small cell lung cancer clinical trial?
To join a small cell lung cancer clinical trial: 1) Browse the available studies on this page, 2) Click on a study that interests you, 3) Check the study locations to find a site near you, 4) Review the eligibility criteria, and 5) Contact the study site or complete the eligibility form. The process is free and you can withdraw at any time.
Are small cell lung cancer clinical trials free?
Yes, participation in small cell lung cancer clinical trials is free. Study-related treatments, medical tests, and doctor visits are provided at no cost to participants. Many studies also offer compensation for your time and travel expenses.
What types of small cell lung cancer treatments are being studied?
Current small cell lung cancer clinical trials are testing a range of approaches across PHASE3 (57 studies), PHASE2 (27 studies), PHASE1 (20 studies), NA (2 studies). These include new drugs, combination therapies, medical devices, and other interventions sponsored by 51 research organizations.
Is it safe to participate in small cell lung cancer clinical trials?
Clinical trials are carefully regulated by the FDA and institutional review boards (IRBs). All trials must follow strict safety protocols, and participants receive close medical monitoring throughout the study. You can withdraw from a trial at any time without penalty.
Data updated July 16, 2026 from ClinicalTrials.gov
About This Data
Data: ClinicalTrials.gov · Source of record for eligibility and locations
Clinical trial information on this page is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health (NIH) and National Library of Medicine (NLM). Study data is refreshed every hour to ensure accuracy.
Medical Disclaimer: The information provided on this page is for informational purposes only and does not constitute medical advice. Always consult with a qualified healthcare provider before making decisions about clinical trial participation or changes to your treatment plan.
Page reviewed by the HelloStudys Research Team · Last updated July 16, 2026 · Data from ClinicalTrials.gov